MUCOSOLVAN TAB; ambroxol, respiratory tract agents .
ACTIVE-INGREDIENT OF MUCOSOLVAN TAB
mucosolvan tablets : each tablet contains 30 mg Ambroxol hydrochloride.
INDICATION OF MUCOSOLVAN TAB
secretolytic therapy in acute and chronic bronchopulmonary diseases associated with abnormal mucus secration and impaired mucous transport , such as acute exacerbation of chronic bronchitis , bronchiectasis , asthmoid bronchitis and bronchial asthma . – in pre-and post operative treatment . – the ampoules are especially suitable for prevention of the pulmonary complications in intensive medicine .
DOSAGE OF MUCOSOLVAN TAB
Follow all directions given to you by your pharmacist or doctor carefully . They may differ from the information contained in this leaflet
Ask your pharmacist or doctor for help if you do not understand the instructions on the box .
The recommended dose is : –
the recommendations for children are based on a total daily dose of 1.2 – 1.6 mg / kg b.wt. . Unless otherwise prescribed : mucosolvan tablets : adults : 1 tablet 3 times daily . In long-term therapy , the dose may be reduced to twice daily . the tablets should be taken after meals with liquid .
OVER-DOSAGE OF MUCOSOLVAN TAB
a) signs of overdosage : intoxications in man are not known . Ambroxol was well tolerated up to a dosage of 15 mg / kg b.wt. per day with parenteral administration . The acute toxic symptoms in case of extreme overdosage were in preclinical investigations increased salivation, retching , vomiting and drop in blood pressure . b) treatment of overdosage : in case of accidental or intentional extreme overdosage the cardiovascular system should be monitored and if neccessary sysmptomatic measures should be taken .
CONTRA-INDICATION OF MUCOSOLVAN TAB
known hypersensitivity to ambroxol .
STORAGE OF MUCOSOLVAN TAB
store at room temperature in cool and dry place .
PACK OF MUCOSOLVAN TAB
mucosolvan tablets : box of 20 tablets ( 2 strips each contains 10 tablets ) .
MUCOSOLVAN TAB MANUFACTURED BY
chemical industries development (CID )